Efficacy and safety of a quadruple ultra-low-dose treatment for hypertension (QUARTET USA): Rationale and design for a randomized controlled trial

Abigail S. Baldridge*, Mark D. Huffman, Danielle Lazar, Hiba Abbas, Fallon M. Flowers, Adriana Quintana, Alema Jackson, Sadiya S. Khan, Aashima Chopra, My Vu, Priya Tripathi, Tyler Jacobson, Olutobi A. Sanuade, Namratha R. Kandula, Stephen D. Persell, James J. Paparello, Linda L. Rosul, Jairo Mejia, Donald M. Lloyd-Jones, Clara K. ChowJody D. Ciolino

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of a quadruple ultra-low-dose treatment for hypertension (QUARTET USA): Rationale and design for a randomized controlled trial'. Together they form a unique fingerprint.

INIS

Pharmacology, Toxicology and Pharmaceutical Science